- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07597265
Caffeinated Gum Use and Volleyball Performance
Acute Effects of Caffeinated Gum Use on Volleyball Performance: A Randomized, Placebo-Controlled Crossover Trial
This study examined the acute effects of caffeinated chewing gum on volleyball performance in trained female volleyball players. Caffeine is commonly used by athletes to improve performance, but less is known about whether caffeinated gum is useful during volleyball-specific activity.
Participants completed three testing sessions in a randomized crossover design. In one session, they chewed placebo gum. In another session, they chewed caffeinated gum containing a single 300 mg dose of caffeine. In the third session, they received the same total amount of caffeine as three separate 100 mg doses given at 30-minute intervals.
The study assessed volleyball-specific skill performance, including attack, block, and defense efficiency, during a volleyball-specific skill game. Vertical jump height, heart rate, perceived exertion, side effects, and condition guessing were also recorded.
Study Overview
Status
Conditions
Detailed Description
This randomized, placebo-controlled, crossover study investigated whether the pattern of caffeinated gum administration affects volleyball-specific performance in trained female volleyball players. Participants completed one familiarization session and three experimental sessions separated by one week. The experimental conditions were placebo gum, single-dose caffeinated gum, and partial-dose caffeinated gum.
In the single-dose condition, participants chewed three pieces of caffeinated gum containing a total of 300 mg caffeine for 5 minutes. In the partial-dose condition, participants chewed one piece of caffeinated gum containing 100 mg caffeine at three different time points, with 30-minute intervals between doses. In the placebo condition, participants chewed caffeine-free gum for 5 minutes.
Each testing session included volleyball-specific activities and a 30-minute volleyball-specific skill game. Attack, block, and defense efficiency were assessed using video recordings and Data Volley software. Vertical jump height was measured before and after the volleyball-specific activity. Heart rate was recorded during the session, and rating of perceived exertion was assessed before and after the session. Participants were also asked to report side effects and to guess which condition they had received after each session.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bornova
-
Izmir, Bornova, Turkey (Türkiye), 35040
- Ege University, Faculty of Sport Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female volleyball players aged 18 to 35 years.
- Apparently healthy.
- Daily caffeine intake ≤300 mg.
- Minimum of 5 years of regular volleyball training experience.
- Training for at least 120 minutes at least 3 days per week.
- Competing in national or international volleyball matches.
- Provided written informed consent before participation.
Exclusion Criteria:
- Serious injury or trauma within the past 6 months that could affect volleyball performance.
- Illness or inability to continue the study protocol during the research period.
- Development of side effects during caffeinated gum administration that prevented continuation.
- Regular alcohol or drug use that could affect the study outcomes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Placebo, Single-Dose Caffeine, Partial-Dose Caffeine Arm Type: Experimental
Participants received placebo gum in the first session, single-dose caffeinated gum in the second session, and partial-dose caffeinated gum in the third session.
Sessions were separated by one week.
|
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine.
The gum was chewed for 5 minutes and then discarded.
Other Names:
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece.
One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Other Names:
Participants chewed caffeine-free placebo gum for 5 minutes.
The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Other Names:
|
|
Experimental: Placebo, Partial-Dose Caffeine, Single-Dose Caffeine
Participants received placebo gum in the first session, partial-dose caffeinated gum in the second session, and single-dose caffeinated gum in the third session.
Sessions were separated by one week.
|
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine.
The gum was chewed for 5 minutes and then discarded.
Other Names:
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece.
One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Other Names:
Participants chewed caffeine-free placebo gum for 5 minutes.
The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Other Names:
|
|
Experimental: Single-Dose Caffeine, Placebo, Partial-Dose Caffeine
Participants received single-dose caffeinated gum in the first session, placebo gum in the second session, and partial-dose caffeinated gum in the third session.
Sessions were separated by one week.
|
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine.
The gum was chewed for 5 minutes and then discarded.
Other Names:
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece.
One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Other Names:
Participants chewed caffeine-free placebo gum for 5 minutes.
The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Other Names:
|
|
Experimental: Single-Dose Caffeine, Partial-Dose Caffeine, Placebo
Participants received single-dose caffeinated gum in the first session, partial-dose caffeinated gum in the second session, and placebo gum in the third session.
Sessions were separated by one week.
|
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine.
The gum was chewed for 5 minutes and then discarded.
Other Names:
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece.
One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Other Names:
Participants chewed caffeine-free placebo gum for 5 minutes.
The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Other Names:
|
|
Experimental: Partial-Dose Caffeine, Placebo, Single-Dose Caffeine
Participants received partial-dose caffeinated gum in the first session, placebo gum in the second session, and single-dose caffeinated gum in the third session.
Sessions were separated by one week.
|
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine.
The gum was chewed for 5 minutes and then discarded.
Other Names:
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece.
One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Other Names:
Participants chewed caffeine-free placebo gum for 5 minutes.
The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Other Names:
|
|
Experimental: Partial-Dose Caffeine, Single-Dose Caffeine, Placebo
Participants received partial-dose caffeinated gum in the first session, single-dose caffeinated gum in the second session, and placebo gum in the third session.
Sessions were separated by one week.
|
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine.
The gum was chewed for 5 minutes and then discarded.
Other Names:
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece.
One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Other Names:
Participants chewed caffeine-free placebo gum for 5 minutes.
The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attack efficiency
Time Frame: During the 30-minute volleyball-specific skill game in each experimental trial
|
Attack efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software.
Values were expressed as percentages.
|
During the 30-minute volleyball-specific skill game in each experimental trial
|
|
Block efficiency
Time Frame: During the 30-minute volleyball-specific skill game in each experimental trial
|
Block efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software.
Values were expressed as percentages.
|
During the 30-minute volleyball-specific skill game in each experimental trial
|
|
Defense efficiency
Time Frame: During the 30-minute volleyball-specific skill game in each experimental trial
|
Defense efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software.
Values were expressed as percentages.
|
During the 30-minute volleyball-specific skill game in each experimental trial
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in vertical jump height
Time Frame: From immediately before to immediately after each experimental trial
|
Vertical jump height was measured before and after each experimental testing session using a photoelectric cell system.
Values were expressed in centimeters.
|
From immediately before to immediately after each experimental trial
|
|
Heart rate
Time Frame: Continuously during each experimental trial
|
Heart rate was recorded during each experimental testing session using a telemetric heart rate monitoring system.
Values were expressed as beats per minute.
|
Continuously during each experimental trial
|
|
Change in rating of perceived exertion
Time Frame: From immediately before to immediately after each experimental trial
|
Rating of perceived exertion was assessed before and after each experimental testing session using a 0-10 Borg scale.
|
From immediately before to immediately after each experimental trial
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Side effects
Time Frame: Immediately after each experimental trial
|
Participants were asked after each experimental testing session whether they experienced any side effects or discomfort related to the gum intervention.
Reported responses were recorded descriptively.
|
Immediately after each experimental trial
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EGE-25-9.1T-28
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Performance
-
Ankara UniversityBurdur Mehmet Akif Ersoy UniversityCompletedAnaerobic Performance Neuromuscular Performance Cognitive PerformanceTurkey (Türkiye)
-
Lindenwood UniversityCompletedExercise Performance | Exercise Performance of Fit Athletes | Cycling PerformanceUnited States
-
Shanghai University of SportRecruitingAthletic Performance | Physical PerformanceChina
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
University of GaziantepCompletedExercise Performance | Physical PerformanceTurkey (Türkiye)
-
Gümüşhane UniversıtyCompletedInspiratory Muscle Training | Jump Performance | Shooting Performance | Precision Sport PerformanceTurkey (Türkiye)
-
University of MoliseGiuseppe Calcagno; Giovanni Fiorilli; Andrea Buonsenso; Alessandra di CagnoCompletedAcademic Acheivement | Cognitive Performance | Physical PerformanceItaly
-
Krzysztof MizeraCompletedCognitive Performance | Physical PerformancePoland
-
Sinop UniversityCompletedAthletic Performance | Cognitive Performance | Healthy Adult FemalesTurkey (Türkiye)
-
Société des Produits Nestlé (SPN)UCAM universityCompletedEndurance Cycling Performance | Performance | Endurance Exercise | SupplementSpain
Clinical Trials on Single-dose caffeinated gum
-
Muttalip AyarCompletedAthletic PerformanceTurkey (Türkiye)
-
China Medical University HospitalCompletedSleep Quality | Cognitive PerformanceTaiwan
-
Mayo ClinicCompleted
-
Brilliant Inspiration BiotherapeuticsActive, not recruiting
-
Taiho Pharmaceutical Co., Ltd.CompletedStress Urinary IncontinenceJapan
-
AblynxCompletedHealthy VolunteersUnited States
-
Otsuka Beijing Research InstituteChinese Academy of Medical Sciences, Fuwai HospitalCompleted
-
Basilea PharmaceuticaCompleted
-
Galapagos NVCompleted